PIMA541729
Blinatumomab Recombinant Mouse Monoclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIMA541729-Each-of-1 | In Stock | ₹ 45,790.50 |
PIMA541729 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 45,790.50
GST (18%): ₹ 8,242.29
Total Price: ₹ 54,032.79
Antigen
Blinatumomab
Classification
Recombinant Monoclonal
Conjugate
Unconjugated
Gene Alias
AMG103; BITE MT-103; bscCD19xCD3; MEDI-538; MT103
Immunogen
Human CD19/CD3E
Quantity
100 μg
Primary or Secondary
Primary
Content And Storage
-20° C, Avoid Freeze/Thaw Cycles
Form
Liquid
Target Molecule
Chemical
Applications
ELISA
Concentration
1.42 mg/mL
Formulation
30mM histidine with 0.02% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species
Mouse
Purification Method
Metal-chelate chromatography
Regulatory Status
RUO
Target Species
Chemical
Product Type
Antibody
Isotype
scFv κ
Related Products
Description
- Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles
- Store at 2 to 8 °C for one week
- Store at -20 to -80 °C for twelve months from the date of receipt
- Blinatumomab is a BiTE-class (bi-specific T-cell engagers) constructed monoclonal antibody indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)
- Blinatumomab is manufactured by Amgen Inc
- and marketed under the brand Blincyto™
- Blinatumomab was approved in December 2014 under the FDA's accelerated approval program, which allows approval of a pharmaceutical to treat a serious or life-threatening disease based on clinical data showing the pharmaceutical has an effect on a surrogate endpoint reasonably likely to predict clinical benefit to patients.
Compare Similar Items
Show Difference
Antigen: Blinatumomab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: AMG103; BITE MT-103; bscCD19xCD3; MEDI-538; MT103
Immunogen: Human CD19/CD3E
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 1.42 mg/mL
Formulation: 30mM histidine with 0.02% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species: Mouse
Purification Method: Metal-chelate chromatography
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: scFv κ
Antigen:
Blinatumomab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
AMG103; BITE MT-103; bscCD19xCD3; MEDI-538; MT103
Immunogen:
Human CD19/CD3E
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
1.42 mg/mL
Formulation:
30mM histidine with 0.02% Tween 80, 10% sucrose and no preservative; pH 5.8
Host Species:
Mouse
Purification Method:
Metal-chelate chromatography
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
scFv κ
Antigen: Yth12.5
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: CD3E; YTH12.5
Immunogen: Human CD3E
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA
Concentration: 3.95 mg/mL
Formulation: PBS with no preservative; pH 7.5
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1
Antigen:
Yth12.5
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
CD3E; YTH12.5
Immunogen:
Human CD3E
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA
Concentration:
3.95 mg/mL
Formulation:
PBS with no preservative; pH 7.5
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1
Antigen: 4F2Mab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: 14G2a; 4F2
Immunogen: Human ganglioside GD2/ SFRP1/SLC3A2
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Human
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1, IgG2a
Antigen:
4F2Mab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
14G2a; 4F2
Immunogen:
Human ganglioside GD2/ SFRP1/SLC3A2
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Human
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1, IgG2a
Antigen: Abagovomab
Classification: Recombinant Monoclonal
Conjugate: Unconjugated
Gene Alias: ACA125; MEN-2234; OC126
Immunogen: Human idiotope of anti- Mus musculus monoclonal antibody
Quantity: 100 μg
Primary or Secondary: Primary
Content And Storage: -20° C, Avoid Freeze/Thaw Cycles
Form: Liquid
Target Molecule: Chemical
Applications: ELISA, SDS-Page
Concentration: 1 mg/mL
Formulation: PBS with no preservative; pH 7.4
Host Species: Mouse
Purification Method: Protein A
Regulatory Status: RUO
Target Species: Chemical
Product Type: Antibody
Isotype: IgG1 κ
Antigen:
Abagovomab
Classification:
Recombinant Monoclonal
Conjugate:
Unconjugated
Gene Alias:
ACA125; MEN-2234; OC126
Immunogen:
Human idiotope of anti- Mus musculus monoclonal antibody
Quantity:
100 μg
Primary or Secondary:
Primary
Content And Storage:
-20° C, Avoid Freeze/Thaw Cycles
Form:
Liquid
Target Molecule:
Chemical
Applications:
ELISA, SDS-Page
Concentration:
1 mg/mL
Formulation:
PBS with no preservative; pH 7.4
Host Species:
Mouse
Purification Method:
Protein A
Regulatory Status:
RUO
Target Species:
Chemical
Product Type:
Antibody
Isotype:
IgG1 κ